Published June 2, 2020 | Version v1
Journal article Open

Diagnostic and therapeutic challenges of Myasthenia Gravis: A report of 2 cases

Authors/Creators

  • 1. Department of Neurology, Medical University of Lublin, Lublin, Poland

Description

Myasthenia gravis (MG) is an autoimmune disease that affects the neuromuscular junction and is characterized by muscle weakness. We present two clinical cases of patients with MG. The first case of the patient presents an uncharacteristic clinical picture in the form of dyspnoea with stridor. The second clinical case presents a severe form of MG, resistant to pharmacological cholinergic and immunosuppressive treatment, which resulted in a satisfactory improvement after eight plasmapheresis treatments and the conversion of pyridostigmine to the ambenonium.

Files

WNOFNS 31 (2020) 138-145.pdf

Files (401.4 kB)

Name Size Download all
md5:f1f4d437e6d925e177da4b6a327bf6b3
401.4 kB Preview Download

Additional details

Identifiers

URL
https://www.worldnewsnaturalsciences.com/wp-content/uploads/2020/04/WNOFNS-31-2020-138-145.pdf

Related works

Cites
Journal article: https://www.worldnewsnaturalsciences.com/wp-content/uploads/2020/04/WNOFNS-31-2020-138-145.pdf (URL)

Software

Repository URL
https://www.worldnewsnaturalsciences.com/
Development Status
Active

References

  • [1] Evoli. Myasthenia gravis: new developments in research and treatment. Curr Opin Neurol. 30(5) (2017) 464-470
  • [2] M. Padilla Parrado, J.M. Morales Puebla, M.A. Díaz Sastre, et al. Respiratory stridency by larynx paralysis. Anusual beginning of miastenia. An Otorrinolaringol Ibero Am. 33(3) (2006) 307-315
  • [3] J.W. Fairley, M. Hughes. Acute stridor due to bilateral vocal fold paralysis as a presenting sign of myasthenia gravis. J Laryngol Otol. 106(8) (1992) 737-748
  • [4] Emeryk-Szajewska, M.H. Strugalska-Cynowska. Clinical picture of myasthenia gravis: diagnostic difficulties. Pol Przegl Neurol. 2(3) (2006) 145-149
  • [5] M.H. Strugalska-Cynowska. Myasthenia gravis and Lambert-Eaton myasthenic syndrome (clinical and immunological advances, signifity of autoantibodies for diagnosis and treatment). Pol Przegl Neurol. 15(1) (2019) 75-76
  • [6] W. Hoch, J. McConville, S. Helms, et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylocholine receptor antibodies. Natur Medicine 7 (2001) 365-368
  • [7] H. Murai. Myasthenia gravis: past, present and future. Rinsho Shinkeigaku 54(12) (2014) 947-949
  • [8] Węgrzyn, J. Andres, D. Tomasik. Myasthenic crisis. Case report. Anestezjol Intensyw Terap. 3 (2002) 194-196
  • [9] Z. Rybicki. Intensywna terapia dorosłych. Novus Orbis. 1994, Gdańsk, Poland.
  • [10] N.E. Gilhus. Myasthenia Gravis. N Engl J Med. 375(26) (2016) 2570-2581